TY - JOUR
T1 - Prospective validation of five malnutrition screening and assessment instruments among medical inpatients
T2 - Secondary analysis of a randomized clinical trial
AU - Stalder, Lena
AU - Kaegi-Braun, Nina
AU - Gressies, Carla
AU - Gregoriano, Claudia
AU - Tribolet, Pascal
AU - Lobo, Dileep N.
AU - Gomes, Filomena
AU - Hoess, Claus
AU - Pavlicek, Vojtech
AU - Bilz, Stefan
AU - Sigrist, Sarah
AU - Brändle, Michael
AU - Henzen, Christoph
AU - Thomann, Robert
AU - Rutishauser, Jonas
AU - Aujesky, Drahomir
AU - Rodondi, Nicolas
AU - Donzé, Jacques
AU - Stanga, Zeno
AU - Mueller, Beat
AU - Schuetz, Philipp
N1 - Funding Information:
The study was investigator-initiated and supported by a grant from the Swiss National Science Foundation, Switzerland, to P. Schuetz (SNSF Professorship, PP00P3_150,531) and the Forschungsrat of the Kantonsspital Aarau, Switzerland (1410.000.058 and 1410.000.044). The Institution of P. Schuetz has previously received unrestricted grant money unrelated to this project from Nestle Health Science, Switzerland, and Abbott Nutrition, United States. The institution of Z. Stanga received speaking honoraria and research support from Nestle Health Science, Switzerland, Abbott Nutrition, United States, Fresenius Kabi, Germany and B.Braun, Germany. All other authors report no conflicts of interest.
Funding Information:
The study was investigator-initiated and supported by a grant from the Swiss National Science Foundation, Switzerland, to P. Schuetz (SNSF Professorship, PP00P3_150,531 ) and the Forschungsrat of the Kantonsspital Aarau, Switzerland ( 1410.000.058 and 1410.000.044 ). The Institution of P. Schuetz has previously received unrestricted grant money unrelated to this project from Nestle Health Science, Switzerland, and Abbott Nutrition, United States . The institution of Z. Stanga received speaking honoraria and research support from Nestle Health Science, Switzerland, Abbott Nutrition, United States, Fresenius Kabi, Germany and B.Braun, Germany. All other authors report no conflicts of interest.
Publisher Copyright:
© 2022 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism
PY - 2022/6
Y1 - 2022/6
N2 - Background & aims: Screening for malnutrition upon hospital admission is the first crucial step for proper nutritional assessment and treatment. While several nutritional screening and assessment instruments exist, there is a lack of head-to-head validation of these instruments. We studied the ability of five different nutrition screening and assessment instruments to predict 1-year mortality and response to nutritional treatment in participants of the EFFORT randomized trial. Methods: In this secondary analysis of a Swiss-wide multicenter, randomized clinical trial comparing individualized nutritional support with usual care nutrition in medical inpatients, we prospectively classified patients as low, intermediate, and high nutritional risk based on five nutritional screening and assessment instruments (NRS 2002, SGA, SNAQ, MNA and MUST). Results: Overall mortality at 1-year in the 1866 included patients was 30.4%. There were significant correlations and a significant concordance between all instruments with r-values ranging from 0.23 to 0.55 and kappa values ranging from 0.10 to 0.36. While high nutritional risk was associated with higher mortality in all instruments, SGA and MNA showed the strongest association with adjusted odds ratios of 3.17 (95%CI, 2.18 to 4.61, p < 0.001) and 3.45 (95%CI, 2.28 to 5.22, p < 0.001). When comparing mortality in intervention group patients to control group patients stratified by severity of malnutrition, there was overall no clear trend towards more benefit in patients with more severe malnutrition, with NRS 2002 and SGA showing the most pronounced relationship between the severity of malnutrition and reduction in mortality as a response to nutritional support. Conclusion: Among all five screening and assessment instruments, higher nutritional risk was associated with higher risk for mortality and adverse clinical outcome, but not with more or less treatment response from nutritional support with differences among scores. Adding more specific parameters to these instruments is important when using them to decide for or against nutritional support interventions in an individual patient. Trial registration: ClinicalTrials.gov NCT02517476.
AB - Background & aims: Screening for malnutrition upon hospital admission is the first crucial step for proper nutritional assessment and treatment. While several nutritional screening and assessment instruments exist, there is a lack of head-to-head validation of these instruments. We studied the ability of five different nutrition screening and assessment instruments to predict 1-year mortality and response to nutritional treatment in participants of the EFFORT randomized trial. Methods: In this secondary analysis of a Swiss-wide multicenter, randomized clinical trial comparing individualized nutritional support with usual care nutrition in medical inpatients, we prospectively classified patients as low, intermediate, and high nutritional risk based on five nutritional screening and assessment instruments (NRS 2002, SGA, SNAQ, MNA and MUST). Results: Overall mortality at 1-year in the 1866 included patients was 30.4%. There were significant correlations and a significant concordance between all instruments with r-values ranging from 0.23 to 0.55 and kappa values ranging from 0.10 to 0.36. While high nutritional risk was associated with higher mortality in all instruments, SGA and MNA showed the strongest association with adjusted odds ratios of 3.17 (95%CI, 2.18 to 4.61, p < 0.001) and 3.45 (95%CI, 2.28 to 5.22, p < 0.001). When comparing mortality in intervention group patients to control group patients stratified by severity of malnutrition, there was overall no clear trend towards more benefit in patients with more severe malnutrition, with NRS 2002 and SGA showing the most pronounced relationship between the severity of malnutrition and reduction in mortality as a response to nutritional support. Conclusion: Among all five screening and assessment instruments, higher nutritional risk was associated with higher risk for mortality and adverse clinical outcome, but not with more or less treatment response from nutritional support with differences among scores. Adding more specific parameters to these instruments is important when using them to decide for or against nutritional support interventions in an individual patient. Trial registration: ClinicalTrials.gov NCT02517476.
KW - Assessment
KW - Malnutrition
KW - Nutritional support
KW - Outcomes
KW - Screening
UR - http://www.scopus.com/inward/record.url?scp=85129708421&partnerID=8YFLogxK
U2 - 10.1016/j.clnu.2022.04.025
DO - 10.1016/j.clnu.2022.04.025
M3 - Article
C2 - 35552050
AN - SCOPUS:85129708421
SN - 0261-5614
VL - 41
SP - 1307
EP - 1315
JO - CLINICAL NUTRITION
JF - CLINICAL NUTRITION
IS - 6
ER -